189 related articles for article (PubMed ID: 29240274)
21. The association of Klotho polymorphism with disease progression and mortality in IgA nephropathy.
Ko GJ; Lee EA; Jeon US; Pyo HJ; Chin HJ; Chae DW; Kim S; Kwon YJ
Kidney Blood Press Res; 2012; 36(1):191-9. PubMed ID: 23147162
[TBL] [Abstract][Full Text] [Related]
22. [Association of single nucleotide polymorphism of megsin gene with IgA nephropathy].
Wang ZH; Chen N; Pan XX; Ren H; Wang WM; Zhang W; Hao CL; Zhu J; Lu Y; Han B
Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1337-41. PubMed ID: 16796905
[TBL] [Abstract][Full Text] [Related]
23. Association of angiotensinogen gene M235T polymorphism with the risk of IgA nephropathy: a meta-analysis.
Mao S; Huang S
Ren Fail; 2014 Apr; 36(3):466-72. PubMed ID: 24344785
[TBL] [Abstract][Full Text] [Related]
24. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
[TBL] [Abstract][Full Text] [Related]
25. Association between the AGTR1 A1166C polymorphism and risk of IgA nephropathy: a meta-analysis.
Xu JM; Song X; Gao F; Wang R
Genet Mol Res; 2015 Dec; 14(4):19371-81. PubMed ID: 26782590
[TBL] [Abstract][Full Text] [Related]
26. Interleukin Variants Are Associated with the Development and Progression of IgA Nephropathy: A Candidate-Gene Association Study and Meta-Analysis.
Chronopoulou I; Tziastoudi M; Pissas G; Dardiotis E; Dardioti M; Golfinopoulos S; Filippidis G; Mertens PR; Tsironi EE; Liakopoulos V; Eleftheriadis T; Stefanidis I
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003536
[TBL] [Abstract][Full Text] [Related]
27. C509T and T869C polymorphisms of transforming growth factor β1 and the risk of IgA nephropathy: a meta-analysis.
Xue C; Nie W; Xu J; Dai B; Mei CL
Chin Med J (Engl); 2013 Dec; 126(23):4562-7. PubMed ID: 24286426
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms in TNFSF13 and FDX1 are associated with IgA nephropathy in the Han Chinese population.
Niu D; Gao Y; Xie L; Sun J; Lu W; Jin G; Hao Y; Zhang Y; Yin A; Geng Y; Zhang W; Chen C; Li S
Hum Immunol; 2015 Nov; 76(11):831-5. PubMed ID: 26431901
[TBL] [Abstract][Full Text] [Related]
29. [Trans-ethnic analysis of susceptibility variants in IgA nephropathy].
Kang YQ; Zhang YM; Hou P; Shi SF; Liu LJ; Zhou XJ; Lv JC; Zhang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):459-466. PubMed ID: 31209417
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
Zhou TB; Yin SS; Liang R
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
[TBL] [Abstract][Full Text] [Related]
31. Genetic Variant CFH rs6677604 Might Play a Protective Role in lupus Nephritis.
Tao J; Tan M; Li LL; Chu H; Song D; Tan Y; Wang SX; Qu Z; Yu F
Am J Med Sci; 2021 Mar; 361(3):336-343. PubMed ID: 33309135
[TBL] [Abstract][Full Text] [Related]
32. A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy.
Suh JS; Cho SH; Chung JH; Moon A; Park YK; Cho BS
J Interferon Cytokine Res; 2013 Oct; 33(10):571-7. PubMed ID: 23659670
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants of MCP-1 and CCR2 genes and IgA nephropathy risk.
Gao J; Liu X; Wei L; Niu D; Wei J; Wang L; Ge H; Wang M; Yu Q; Jin T; Tian T; Dai Z; Fu R
Oncotarget; 2016 Nov; 7(47):77950-77957. PubMed ID: 27788494
[TBL] [Abstract][Full Text] [Related]
34. The effects of both single-locus and multi-locus interaction on the clinical manifestations of IgA nephropathy in Southern Han Chinese.
Wang W; Sun Y; Fu Y; Yu X; Li M
Nephrol Dial Transplant; 2014 Mar; 29(3):550-5. PubMed ID: 24271554
[TBL] [Abstract][Full Text] [Related]
35. Association of genetic polymorphisms in IL-23R and IL-17A with the susceptibility to IgA nephropathy in a Chinese Han population.
Liao H; Huang Z; Zhang J; Yang B
Genes Immun; 2022 Feb; 23(1):33-41. PubMed ID: 34952933
[TBL] [Abstract][Full Text] [Related]
36. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy.
Tanaka Y; Suzuki Y; Tsuge T; Kanamaru Y; Horikoshi S; Monteiro RC; Tomino Y
Nephrol Dial Transplant; 2005 Nov; 20(11):2439-45. PubMed ID: 16221721
[TBL] [Abstract][Full Text] [Related]
37. CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis.
Berthoux FC; Berthoux P; Mariat C; Thibaudin L; Afiani A; Linossier MT
Kidney Int; 2006 Feb; 69(3):565-72. PubMed ID: 16395252
[TBL] [Abstract][Full Text] [Related]
38. Three SNPs of FCRL3 and one SNP of MTMR3 are associated with immunoglobulin A nephropathy risk.
Zhang H; He Y; He X; Wang L; Jin T; Yuan D
Immunobiology; 2020 Jan; 225(1):151869. PubMed ID: 31780315
[TBL] [Abstract][Full Text] [Related]
39. Is complement factor H a susceptibility factor for IgA nephropathy?
Edey M; Strain L; Ward R; Ahmed S; Thomas T; Goodship TH
Mol Immunol; 2009 Apr; 46(7):1405-8. PubMed ID: 19162324
[TBL] [Abstract][Full Text] [Related]
40. Shared genetic study gives insights into the shared and distinct pathogenic immunity components of IgA nephropathy and SLE.
Zhang YM; Zhou XJ; Wang YN; Liu XZ; Wang YF; Lau YL; Yang WL; Zhang H
Mol Genet Genomics; 2021 Jul; 296(4):1017-1026. PubMed ID: 34076728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
